ArticleMicroorganisms2024

Tixagevimab/Cilgavimab as SARS-CoV-2 Pre-Exposure Prophylaxis in Lung Transplant Recipients during the Omicron Wave: A Real-World Monocentric Experience.

Andrea Cona et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.